Ashish Verma, MD
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Nephrology

MBBS, Stanley Medical School

Pronouns: he/him/his



Dr. Verma is a clinician-investigator interested in chronic kidney disease (CKD), renal amyloidosis, cardiorenal syndrome, diabetic kidney disease (DKD), renal physiology, and electrolyte abnormalities. Dr. Verma's research projects include epidemiologic investigations utilizing large databases and translational and patient-oriented research projects. Ongoing studies include predictors of CKD progression using CRIC cohort and UK biobank, predictors of mortality using NHANES, a Physiology study examining the role of Kidney Function Reserve and renal plasma flow in phenotyping chronic kidney disease, and the role of intravitreal VEGF inhibitors in causing nephrotoxicity, and renal physiology of decongestion in patients with Acute decompensated heart failure(ADHF). Dr. Verma is a member of the APRC committee for the Framingham Heart Study, the Renal subgroup for clinical endpoints in Amyloidosis for the Amyloidosis research consortium, and the Membership Committee for Kidney in Cardiovascular Medicine for the American Heart Association. He is on the Editorial Board of Therapeutic Advances in Endocrinology and Metabolism, Therapeutic Advances in Chronic Disease, Plos One, and BMC Medicine.



Renal physiology of de-congestion in acute decompensated heart failure
07/01/2024 - 06/30/2027 (PI)
American Heart Association/AHA


Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Claudel SE, Schmidt IM, Waikar SS, Verma A. Albuminuria: A Marker of Adverse Kidney Outcomes in Heart Failure. J Am Coll Cardiol. 2025 Apr 01; 85(12):1372-1375. PMID: 40139894; DOI: 10.1016/j.jacc.2025.01.025;
     
  2. Kar D, Byng R, Sheikh A, Nath M, Zabeen B, Kar S, Banu S, Sarker MHR, Khan N, Acharjee D, Islam S, Allgar V, Ordóñez-Mena JM, El-Wazir A, Song S, Verma A, Kadam U, de Lusignan S. Navigating the complexities of end-stage kidney disease (ESKD) from risk factors to outcome: insights from the UK Biobank cohort. BMC Nephrol. 2025 Apr 01; 26(1):168. PMID: 40169952; DOI: 10.1186/s12882-025-04090-7;
     
  3. Claudel SE, Verma A. Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review. Circulation. 2025 Mar 11; 151(10):716-732.View Related Profiles. PMID: 40063723; DOI: 10.1161/CIRCULATIONAHA.124.071079;
     
  4. Claudel SE, Waikar SS, Verma A. Albuminuria References Ranges in Healthy US Adults. J Appl Lab Med. 2025 Feb 21.View Related Profiles. PMID: 39981782; DOI: 10.1093/jalm/jfaf015;
     
  5. Claudel SE, Schmidt IM, Waikar SS, Verma A. Cumulative Incidence of Mortality Associated with Cardiovascular-Kidney-Metabolic (CKM) Syndrome. J Am Soc Nephrol. 2025 Feb 11.View Related Profiles. PMID: 39932805; DOI: 10.1681/ASN.0000000637;
     
  6. Agarwal R, Verma A, Georgianos PI. Diuretics in patients with chronic kidney disease. Nat Rev Nephrol. 2025 Apr; 21(4):264-278. PMID: 39775051; DOI: 10.1038/s41581-024-00918-x;
     
  7. Schmidt IM, Kefalogianni E, Zhao R, Verma A, Sabbisetti V, Rahman M, Pradhan N, Srivastava A, He J, Chen J, Waikar SS, Herrlich A. Associations of Serum Amphiregulin Levels With Kidney Failure and Mortality: The Chronic Renal Insufficiency Cohort (CRIC). Kidney Med. 2025 Mar; 7(3):100958.View Related Profiles. PMID: 40071064; PMCID: PMC11894294; DOI: 10.1016/j.xkme.2024.100958;
     
  8. Anand S, O'Neill-Dee M, Sanchorawala V, Verma A. Light-chain (AL) amyloidosis for nephrologists-treatment standard. Nephrol Dial Transplant. 2024 Dec 20; 40(1):34-47.View Related Profiles. PMID: 39375844; DOI: 10.1093/ndt/gfae224;
     
  9. Claudel SE, Verma A. Social Determinants of Health and Cumulative Incidence of Mortality Among US Adults Without Major Chronic Diseases. J Gen Intern Med. 2024 Dec 11.View Related Profiles. PMID: 39663346; DOI: 10.1007/s11606-024-09275-8;
     
  10. Claudel SE, Waikar SS, Schmidt IM, Vasan RS, Verma A. The relationship between low levels of albuminuria and mortality among adults without major cardiovascular risk factors. Eur J Prev Cardiol. 2024 Dec 04; 31(17):2046-2055.View Related Profiles. PMID: 38825979; PMCID: PMC11629963; DOI: 10.1093/eurjpc/zwae189;
     
Showing 10 of 67 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 67 publications over 11 distinct years, with a maximum of 13 publications in 2020 and 2023

YearPublications
20132
20151
20171
20184
20191
202013
20216
202210
202313
202410
20256

Note: X.com has changed/limited the ability to embed tweets directly in external sites and we are investigating ways to restore that functionality in BU Profiles. In the meantime we are displaying a link to your x.com profile in the Websites section above.

Albuminuria Emerges As Key Predictor Of Chronic Kidney Disease Progression: Landmark Cohort Study Unveils Critical Findings

Medical Dialogues 6/12/2024

What is CKM Syndrome? Report Finds Most Americans Meet Criteria For Early Stages

Health 5/21/2024

Even Normal-Range Albuminuria May Increase Risk of CKD Progression, Kidney Failure

HCP Live 4/10/2024

Elevated Albuminuria, Even Within Normoalbuminuric Range, May Be Linked to Elevated Risk for CKD Progression, Hepatic Failure

Patient Care 4/10/2024

Patients with CKD and Normoalbuminuria May Have Higher Risk for Disease Progression

Healio 4/4/2024

CKD Progression Risk Up With Increasing Albuminuria in Normal Range

Physician's Weekly 4/2/2024

CKD Progress Risk Increased Even if Albuminuria Range Normal

Medscape 4/2/2024

CKD Progression Risk Up With Increasing Albuminuria in Normal Range

Health Day 4/1/2024

What Is CKM Syndrome? American Heart Association Identifies New Medical Condition

Health 10/17/2023

High Aldosterone Levels Increase Risk for CKD Progression

Medscape 8/10/2022

Aldosterone, a hormone that prevents dehydration, is linked to worsening kidney disease, study suggests

STAT 8/8/2022

Aldosterone Linked to Kidney Failure Risk, Irrespective of Diabetes

Medpage Today 8/8/2022

2024 American Heart Association : Career Development Award
2024 Annals of Internal Medicine : Best reviewer
2024 Department of Medicine, BUCAMS: DOM Investment Award
2023 Nephrology Dialysis Transplantation(NDT) Journal: Editorial Fellow
2023 European Renal Association: Member of Young Nephrologist's Platform
2021 American Society of Nephrology: Fellow of American Society of Nephrology
2019 Brigham and Women's Hospital: Fellowship Teaching Award, Department of Medicine
2019 American Society of Nephrology: Fellowship in Training Bowl Champion
2018 University of Tennessee College of Medicine, Chattanooga: Best Resident Research Award
2018 University of Tennessee College of Medicine, Chattanooga: Academic Honors
2017 American College of Physicians: Internal medicine Jeopardy Champion-Tennesse State
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Chronic Kidney Disease
Epidemiology
Acute Kidney Injury
Machine Learning
Acidosis
Electrolyte Balance
Cardiorenal Syndromes
Renal Physiology
Hypertension
Aldosterone
Biomarkers
COVID-19

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Diversity Mentor
  • Education Mentor
  • Project Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')

650 Albany St
Boston MA 02118
Google Map

617.638.7339
Download vCard

Verma's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (194) concept(s)
_
Media Mentions
_
Co-Authors
See all (26) people
_
Similar People
See all (60) people
_
Same Department
Search Department